Journal profile · UROLOGY & NEPHROLOGY
Kidney360
ISSN 2641-7650 · Wolters Kluwer Health
Kidney360: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.6 (journal website); JCR Q1 (journal website); fully open access; APC about USD 1,800; median 129 days to acceptance (50 articles, last 24 months); 403 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Kidney360 is published by Wolters Kluwer Health and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Dialysis and Renal Disease Management, Chronic Kidney Disease and Diabetes and Renal Diseases and Glomerulopathies, together about 35.8% of its articles. Its main subfields are Nephrology. (generated from OpenAlex topic counts and CAS ranking data)
Large volumes of polyethylene glycol (PEG) solution reduce patient acceptance of colonoscopy. A prepackaged low-residue diet (PLRD; Clear-Through) may improve bowel cleansing and allow further PEG reduction. This exploratory randomized study evaluated whether PLRD permits decreased PEG with ascorbic acid (PEG-Asc) volume while maintaining cleansing quality.
From the journal's Aims & Scope
Research area (LetPub): UROLOGY & NEPHROLOGY
Editor-in-chief Charuhas V. ThakarPublisher website
Editorial board by country: none in mainland China; most named United Kingdom 2, Egypt 1 (3 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Dialysis and Renal Disease ManagementMedicine16.2%
- Chronic Kidney Disease and DiabetesMedicine11.2%
- Renal Diseases and GlomerulopathiesMedicine8.4%
- Acute Kidney Injury ResearchMedicine8.3%
- Renal Transplantation Outcomes and TreatmentsMedicine6.8%
- Organ Donation and TransplantationMedicine4.6%
- Central Venous Catheters and HemodialysisHealth Professions4.3%
- Genetic and Kidney Cyst DiseasesBiochemistry, Genetics and Molecular Biology3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Urology & Nephrology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Urology & Nephrology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- JCR Q1 · UROLOGY & NEPHROLOGY · rank 28/134
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 3.6Publisher website ·
- CiteScore 2026-06
- 4.4LetPub ·
- SJR 2026-06
- 1.06LetPub ·
- SNIP 2026-06
- 0.99LetPub ·
- h-index
- 44OpenAlex ·
- i10-index
- 515OpenAlex ·
- 2-year mean citedness
- 2.16OpenAlex ·
- Self-citation rate
- 2.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 186LetPub ·
Articles by year OpenAlex count · 2,166 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 268 | 268 | 42 |
| 2025 | 403 | 403 | 577 |
| 2024 | 324 | 324 | 1,528 |
| 2023 | 268 | 268 | 1,813 |
| 2022 | 313 | 313 | 3,047 |
| 2021 | 306 | 306 | 4,335 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
129 daysMedian, submission to acceptance · P25–P75 86 days – 172 days
- Acceptance to online
- median 12 days (50 articles)
- Submission to online
- median 139 days
- Sample
- 50 articles with submission and acceptance dates (760 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to publication (journal-reported)
- about 19 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,800 | Yes | CC BY, CC BY-NC-ND |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Health
- ISSN
- 2641-7650
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Kidney360
What CAS zone is Kidney360 in?
In the 2025 upgraded edition of the CAS Journal Ranking, Kidney360 is in Zone 3 of Medicine, and in Zone 3 of the minor category Urology & Nephrology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Kidney360?
The journal's website gives an impact factor of 3.6; this is the journal's own figure, as LetPub lists none for it; CiteScore 4.4, h-index 44.
How long does peer review take at Kidney360?
Based on the dates recorded on 50 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 129 days (interquartile range 86–172 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Kidney360 in?
The journal's website gives JCR Q1; by category, UROLOGY & NEPHROLOGY Q1 (28/134). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 3 of Medicine.
Where are the editorial board members of Kidney360 based?
Of the 3 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (2) and Egypt (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Kidney360?
According to LetPub and DOAJ records, Kidney360 is indexed in ESCI, Scopus and DOAJ.
Is Kidney360 open access, and what is the APC?
Kidney360 is a fully open-access journal. APC about USD 1,800.
Sources and updates
The facts on this page come from LetPub, DOAJ, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .